Brown-Forman Corporation — Form 10-Q summary
Reporting period: Fiscal third quarter and nine months ended January 31, 2024, compared with the periods ended January 31, 2023. The filing is for fiscal Q3 2024, notwithstanding the request metadata’s “2023 Q3” label. Dollar amounts are in millions except per-share data.
Financial performance
| Metric | Three months ended Jan. 31, 2024 | Nine months ended Jan. 31, 2024 |
|---|---|---|
| Net sales | $1,069; down 1% | $3,214; up 1% |
| Gross profit / margin | $635 / 59.4% | $1,957 / 60.9% |
| Operating income / margin | $373 / 34.9% | $1,039 / 32.3% |
| Net income | $285 | $758 |
| Diluted EPS | $0.60 | $1.58 |
| Operating cash flow | Not presented separately for the quarter | $362, versus $410 |
For the nine-month period, reported gross margin rose 2.5 percentage points year over year. Management attributed the improvement chiefly to favorable price/mix, lower supply-chain disruption costs, and lower tariff-related costs, partly offset by input-cost inflation, foreign exchange, and the Finlandia transition services agreement (TSA). Nine-month operating income increased 25%; diluted EPS increased 32%.
Cash and cash equivalents were $589 at January 31, 2024, versus $374 at April 30, 2023. Short-term borrowings were $728, including $730 par value of commercial paper, versus $235 at fiscal year-end; long-term debt was $2,678, unchanged. The company had a $900 commercial paper program backed by a $900 credit facility expiring in May 2028. Nine-month capital expenditures were $148. Operating cash flow was down $48 year over year, primarily reflecting higher inventory; inventories increased to $2,529 from $2,283 at April 30, 2023.
Changes and notable items
- Nine-month sales growth was driven by favorable price/mix and acquisitions and divestitures, largely offset by lower volumes. Organic net sales were flat. Management noted an estimated net decrease in distributor inventories.
- Reported nine-month sales increased in emerging markets and Travel Retail, while the United States and developed international markets declined. Whiskey sales fell 2%; ready-to-drink sales rose 8%. Jack Daniel’s Tennessee Whiskey (JDTW) sales declined 6%, while Jack Daniel’s Tennessee Apple rose 44% and New Mix rose 34%.
- The quarter’s operating income and earnings comparisons were significantly affected by unusual items. The company recorded a $90 pre-tax gain on the November 2023 Finlandia sale; the prior-year period included a $96 non-cash Finlandia brand impairment and acquisition-related costs. The gain and other items make reported growth less representative of underlying performance; nine-month organic operating income growth was 2%.
- Brown-Forman sold Finlandia for $194 cash and entered into a TSA. It also agreed to sell Sonoma-Cutrer for $50 cash and an approximately 21.5% ownership interest in The Duckhorn Portfolio; closing was expected in fiscal Q4 2024, subject to conditions.
- Cash provided by investing activities was $63, versus $1,300 used in the prior-year nine-month period, reflecting the prior-year Gin Mare and Diplomático acquisitions and current-year Finlandia sale proceeds. Financing activities used $212, including $400 of share repurchases and $300 of dividends paid. The $400 repurchase authorization was completed in December 2023.
Outlook, risks, and contingencies
Management revised its fiscal 2024 outlook, citing challenging conditions after two years of double-digit organic sales growth, evolving macroeconomic conditions, and normalizing industry trends. It expects organic net sales to be flat, organic operating income growth of 0%–2%, an effective tax rate of approximately 20%–22%, and capital expenditures of $230–$240.
Risks identified include dependence on the Jack Daniel’s family of brands, competition, consumer and category shifts, distributor inventory and route-to-consumer changes, supply-chain and input-cost pressures, foreign exchange, tariffs and other regulation, economic conditions, and acquisition or divestiture execution. The company reported no material changes to the risk factors in its 2023 Form 10-K. It stated that pending litigation is not expected to have a material adverse effect and recorded no material accrued loss contingencies at January 31, 2024.
Important facts for investors to verify
- How much of reported operating income and EPS growth reflects the Finlandia gain and the prior-year impairment and acquisition costs, versus recurring operations.
- Whether flat organic sales guidance and 0%–2% organic operating income growth remain achievable, given lower volumes and distributor inventory reductions.
- Whether inventory growth and higher short-term borrowing persist, and their effect on operating cash flow, interest costs, and liquidity.
- The closing and final consideration for the Sonoma-Cutrer transaction, and the financial effects of the Finlandia TSA.
- How reported results compare with organic measures, which are non-GAAP and depend on management’s stated adjustments.